BlackRock Advisors’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $683K | Buy |
21,411
+2,480
| +13% | +$79.1K | ﹤0.01% | 1989 |
|
|
2016
Q3 | $686K | Buy |
18,931
+3,012
| +19% | +$109K | ﹤0.01% | 1962 |
|
|
2016
Q2 | $361K | Buy |
15,919
+2,886
| +22% | +$65.4K | ﹤0.01% | 2248 |
|
|
2016
Q1 | $245K | Buy |
13,033
+893
| +7% | +$16.8K | ﹤0.01% | 2414 |
|
|
2015
Q4 | $199K | Sell |
12,140
-4,037
| -25% | -$66.2K | ﹤0.01% | 2538 |
|
|
2015
Q3 | $178K | Sell |
16,177
-572
| -3% | -$6.29K | ﹤0.01% | 2752 |
|
|
2015
Q2 | $218K | Buy |
16,749
+1,339
| +9% | +$17.4K | ﹤0.01% | 2708 |
|
|
2015
Q1 | $267K | Buy |
15,410
+2,427
| +19% | +$42.1K | ﹤0.01% | 2483 |
|
|
2014
Q4 | $194K | Sell |
12,983
-650
| -5% | -$9.71K | ﹤0.01% | 2613 |
|
|
2014
Q3 | $314K | Sell |
13,633
-298
| -2% | -$6.86K | ﹤0.01% | 2288 |
|
|
2014
Q2 | $444K | Buy |
+13,931
| New | +$444K | ﹤0.01% | 2065 |
|